Top Market Insights Stories
Employer-Paid
Gene therapies are shaking up employer health spend
By Kristen SmithbergEBRI finds utilization remains low, but seven-figure treatments pose growing risk for smaller self-insured employers.
EBRI finds utilization remains low, but seven-figure treatments pose growing risk for smaller self-insured employers.